Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT05216523 Completed - COVID-19 Clinical Trials

"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"

BARCOV
Start date: June 24, 2021
Phase:
Study type: Observational

A retrospective study is planned to find out the incidence and association type of respiratory support with barotrauma in Covid-19 cases admitted in Sultan Qaboos University Hospital. As widely known, Covid-19 affects the respiratory system primarily and is the main cause of admission to hospital. Depending upon the severity, different levels of respiratory support are offered to the patients. Normally patients with viral/bacterial respiratory diseases have a low incidence of barotrauma. Since this disease is new and it has been observed that a significant number of covid-19 patients develop barotrauma, hence it is deemed worthwhile to investigate the matter. All the patients admitted to the ward, high dependency unit, and intensive care unit will be scanned and those who developed barotrauma (pneumothorax, surgical emphysema, pneumo-pericardium, and pneumo-mediastinum) will be studied in detail and analyzed. This review is expected to highlight the problem and etiology and we might be able to suggest a management strategy to deal with this problem.

NCT ID: NCT05216510 Active, not recruiting - Clinical trials for Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

COVID-19 DTH
Start date: January 7, 2022
Phase: Phase 1
Study type: Interventional

This dose finding, multi-cohort study is designed to evaluate the safety and efficacy of intradermally-injectedTNX-2100, synthesized SARS-CoV-2 peptide antigens and assess the presence and magnitude of DTH reactions.

NCT ID: NCT05216497 Completed - COVID-19 Clinical Trials

Efficacy and Safety of Ingavirin®, 90 mg Capsules in Patients With COVID-19

Start date: October 6, 2021
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to investigate the efficacy of Ingavirin®, 90 mg capsules in achieving clinical improvement of novel coronavirus disease (COVID-19) symptoms. A secondary goal of this study is to evaluate the safety of Ingavirin®, 90 mg capsules in patients with COVID-19 infection.

NCT ID: NCT05216484 Recruiting - Clinical trials for SARS-CoV-2 Infection

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Start date: February 18, 2022
Phase: Phase 3
Study type: Interventional

To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above, who inoculated the third dose after 6 months since finished two doses schedule of CoronaVac or BBIBP-CorV.

NCT ID: NCT05216471 Active, not recruiting - Clinical trials for Coronavirus Disease 2019

Identify Coronavirus Disease by Chest X-ray

Start date: May 1, 2021
Phase:
Study type: Observational

to identify the diagnostic accuracy of chest X-ray in diagnosis of Coronavirus disease19 .

NCT ID: NCT05215483 Completed - COVID-19 Clinical Trials

Availability and Advice on Test Uptake During the COVID-19 Pandemic: a Vignette Study.

Start date: November 11, 2021
Phase: N/A
Study type: Interventional

Lateral Flow Testing (LFT) use for COVID-19 related symptoms continues to rise, despite governmental advice to test at a test facility. In this study we investigate whether 1) adjusting the governmental testing advice will lead to a collective increase of people who test with COVID-19 symptoms and if this leads to a higher strategy sensitivity.

NCT ID: NCT05214196 Completed - COVID-19 Clinical Trials

The Efficacy of Oral Antiseptics Against COVID-19

Start date: September 1, 2021
Phase: Phase 4
Study type: Interventional

In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.

NCT ID: NCT05213897 Completed - Covid-19 Clinical Trials

Clinical Performance Evaluation of SARS-CoV-2 (COVID-19) Antigen Assay in Point of Care Settings

Start date: January 27, 2022
Phase:
Study type: Observational

The purpose of this study is to evaluate the performance of Freedom For All Diagnostics, Inc.'s colloidal gold immune technology SARS-CoV-2 Antigen investigational assay when compared to a high-sensitivity Emergency Use Authorization (EUA) SARS-CoV-2 RT-PCR assay. The study will evaluate the accuracy in the intended use environment of the SARS-CoV-2 antigen assay when testing is conducted in a CLIA-waived setting (e.g., a physician's office or clinic) by non-laboratory personnel serving in a healthcare facility or setting.

NCT ID: NCT05212974 Not yet recruiting - COVID-19 Clinical Trials

COVID-19 Vaccine Hesitancy Among Nurses

Start date: January 31, 2022
Phase:
Study type: Observational

The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.

NCT ID: NCT05212909 Completed - Anxiety Clinical Trials

Anxiety Level Assessment of Anesthesia Providers During COVID-19 Pandemic

Start date: August 1, 2020
Phase:
Study type: Observational

Healthcare providers caring for acutely ill or critical patients are exposed to constant stressful situations that can lead to psychiatric manifestations. Depression and anxiety derived from stressful work environments can negatively impact the ability to perform at full capacity directly affecting the quality of care the patients receive. The Severe Acute Respiratory Syndrome Coronavirus 2 infection created a sudden and deep crisis involving every sector worldwide not only affecting sick patients and the healthcare system but also the economy, politics, food, and drugs and social interactions. Hospital workers have experienced the crisis first-hand and have witnessed constant death, a decrease in personal protective equipment supplies, exposure to contracting the virus, risk of contagion to others, and overburdened hospital capacity. The aim of this study is to evaluate how the coronavirus disease 2019 (COVID-19) pandemic has affected healthcare workers. Specifically, to evaluate levels of anxiety and identify factors contributing to anxiety on faculty, residents, and nurse anesthetists in our institution.